COMPASS Pathways (CMPS) Short Interest Ratio & Short Volume → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free CMPS Stock Alerts $7.92 +0.08 (+1.02%) (As of 11:15 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media COMPASS Pathways Short Interest DataCurrent Short Interest3,410,000 sharesPrevious Short Interest3,340,000 sharesChange Vs. Previous Month+2.10%Dollar Volume Sold Short$29.22 millionShort Interest Ratio5.3 Days to CoverLast Record DateApril 30, 2024Outstanding Shares68,340,000 sharesPercentage of Shares Shorted4.99%Today's Trading Volume83,751 sharesAverage Trading Volume631,304 sharesToday's Volume Vs. Average13% Short Selling COMPASS Pathways ? Sign up to receive the latest short interest report for COMPASS Pathways and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCMPS Short Interest Over TimeCMPS Days to Cover Over TimeCMPS Percentage of Float Shorted Over Time Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit COMPASS Pathways Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,410,000 shares $29.22 million +2.1%N/A5.3 $8.57 4/15/20243,340,000 shares $27.79 million +6.7%N/A4.7 $8.32 3/31/20243,130,000 shares $26.04 million -0.6%N/A4.3 $8.32 3/15/20243,150,000 shares $31.19 million -15.8%N/A4.6 $9.90 2/29/20243,740,000 shares $38.41 million -4.6%N/A4.9 $10.27 2/15/20243,920,000 shares $41.63 million +10.4%N/A5.8 $10.62 Get the Latest News and Ratings for CMPS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for COMPASS Pathways and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,550,000 shares $40.01 million +1.7%N/A5.7 $11.27 1/15/20243,490,000 shares $29.46 million +14.1%N/A6.6 $8.44 12/31/20233,060,000 shares $26.78 million -29.7%N/A5.7 $8.75 12/15/20234,350,000 shares $34.80 million +12.7%N/A8.3 $8.00 11/30/20233,860,000 shares $23.08 million -1.3%N/A8.4 $5.98 11/15/20233,910,000 shares $23.46 million -4.4%N/A8.9 $6.00 10/31/20234,090,000 shares $23.44 million +0.5%N/A8.7 $5.73 10/15/20234,070,000 shares $24.38 million -1.0%N/A9.1 $5.99 9/30/20234,110,000 shares $30.41 million +4.3%N/A9.1 $7.40 9/15/20233,940,000 shares $37.08 million +0.3%N/A9.2 $9.41 8/31/20233,930,000 shares $35.57 million +3.2%N/A10.6 $9.05 8/15/20233,810,000 shares $29.11 million +3.5%N/A11.1 $7.64 7/31/20233,680,000 shares $34.30 million +6.4%N/A12.4 $9.32 7/15/20233,460,000 shares $31.43 million +44.2%N/A12.1 $9.09 6/30/20232,400,000 shares $19.87 million -1.2%N/A9.1 $8.28 6/15/20232,430,000 shares $19.56 million -3.2%N/A9.6 $8.05 5/31/20232,510,000 shares $18.42 million -8.1%N/A9.5 $7.34 5/15/20232,730,000 shares $23.31 million -0.4%N/A10.2 $8.54 4/30/20232,740,000 shares $21.97 million -1.1%N/A9.9 $8.02 4/15/20232,770,000 shares $27.53 million -35.1%N/A9.7 $9.94 3/31/20234,270,000 shares $42.40 million -6.4%N/A14 $9.93 3/15/20234,560,000 shares $37.48 million -0.7%N/A17 $8.22 2/28/20234,590,000 shares $37.87 million +2.9%N/A17.4 $8.25 2/15/20234,460,000 shares $41.88 million +8.5%N/A17.1 $9.39 1/31/20234,110,000 shares $42.66 million +2.5%N/A15.3 $10.38 1/15/20234,010,000 shares $38.30 million +3.6%N/A14.3 $9.55 12/30/20223,870,000 shares $31.08 million -0.8%N/A13.4 $8.03 12/15/20223,900,000 shares $38.03 million No ChangeN/A13 $9.75 11/30/20223,900,000 shares $40.17 million -1.5%N/A12.5 $10.30 11/15/20223,960,000 shares $42.29 million +1.3%N/A11.9 $10.68 10/31/20223,910,000 shares $41.21 million +0.3%N/A10.9 $10.54 10/15/20223,900,000 shares $36.89 million +1.0%N/A10.5 $9.46 9/30/20223,860,000 shares $41.42 million +0.3%N/A10.2 $10.73 9/15/20223,850,000 shares $56.36 million +5.8%N/A10.6 $14.64Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. 8/31/20223,640,000 shares $59.48 million +7.4%N/A10 $16.34 8/15/20223,390,000 shares $60.65 million -2.6%N/A9.6 $17.89 7/31/20223,480,000 shares $54.25 million -4.1%N/A9.6 $15.59 7/15/20223,630,000 shares $43.89 million +5.2%N/A10.6 $12.09 6/30/20223,450,000 shares $37.33 million +16.6%N/A11 $10.82 6/15/20222,960,000 shares $27.85 million -3.3%N/A9.7 $9.41 5/31/20223,060,000 shares $27.82 million +1.3%N/A10.2 $9.09 5/15/20223,020,000 shares $23.04 million +8.2%N/A10 $7.63 4/30/20222,790,000 shares $25.28 million +3.0%N/A10.3 $9.06 4/15/20222,710,000 shares $34.15 million +9.3%N/A10.2 $12.60 3/31/20222,480,000 shares $31.97 million +9.3%N/A7.8 $12.89 3/15/20222,270,000 shares $26.08 million No ChangeN/A6.3 $11.49 2/28/20222,270,000 shares $32.78 million +9.7%N/A5.1 $14.44 2/15/20222,070,000 shares $31.51 million +13.1%N/A4.2 $15.22 1/31/20221,830,000 shares $28.82 million +16.6%N/A2.5 $15.75 1/15/20221,570,000 shares $28.10 million +3.3%N/A2 $17.90 12/31/20211,520,000 shares $33.59 million +68.6%N/A1.9 $22.10 12/15/2021901,400 shares $21.39 million +11.5%N/A1.2 $23.73 11/30/2021808,700 shares $26.85 million -16.6%N/A1.2 $33.20 11/15/2021970,000 shares $33.86 million -13.4%N/A1.6 $34.91 10/29/20211,120,000 shares $47.26 million +44.7%N/A2 $42.20 10/15/2021774,200 shares $24.94 million +38.2%N/A2.2 $32.22 9/30/2021560,300 shares $16.74 million -0.2%N/A1.7 $29.87 9/15/2021561,300 shares $18.27 million +38.0%N/A1.6 $32.55 8/31/2021406,900 shares $13.79 million -35.3%N/A1.1 $33.90 8/13/2021629,200 shares $19.04 million +16.0%N/A1.6 $30.26 7/30/2021542,300 shares $19.24 million +16.1%1.5%1.3 $35.48 7/15/2021467,100 shares $16.24 million -64.1%1.3%1 $34.76 6/30/20211,300,000 shares $49.60 million -12.8%3.6%2.7 $38.15 6/15/20211,490,000 shares $56.49 million -8.6%4.1%3.3 $37.91 5/28/20211,630,000 shares $56.56 million -12.8%4.5%3.7 $34.70 5/14/20211,870,000 shares $61.32 million +4.5%5.2%4.2 $32.79 4/30/20211,790,000 shares $69.74 million -2.7%5.1%3.8 $38.96 4/15/20211,840,000 shares $66.15 million +14.3%5.2%4.7 $35.95 3/31/20211,610,000 shares $56.83 million +5.9%4.6%4.1 $35.30 3/15/20211,520,000 shares $62.78 million +28.8%4.3%4 $41.30 2/26/20211,180,000 shares $56.89 million +24.6%3.3%3.1 $48.21 2/12/2021947,300 shares $47.35 million -5.3%2.7%2.4 $49.98 1/29/20211,000,000 shares $43.97 million +4.3%N/A3 $43.97 1/15/2021959,200 shares $41.08 million No ChangeN/A2.6 $42.83 CMPS Short Interest - Frequently Asked Questions What is COMPASS Pathways' current short interest? Short interest is the volume of COMPASS Pathways shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 3,410,000 shares of CMPS short. Learn More on COMPASS Pathways' current short interest. What is a good short interest ratio for COMPASS Pathways? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CMPS shares currently have a short interest ratio of 5.0. Learn More on COMPASS Pathways's short interest ratio. Which institutional investors are shorting COMPASS Pathways? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of COMPASS Pathways: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is COMPASS Pathways' short interest increasing or decreasing? COMPASS Pathways saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 3,410,000 shares, an increase of 2.1% from the previous total of 3,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does COMPASS Pathways' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to COMPASS Pathways: SIGA Technologies, Inc. (13.53%), Altimmune, Inc. (31.47%), Olema Pharmaceuticals, Inc. (15.02%), Harrow, Inc. (15.55%), IGM Biosciences, Inc. (29.87%), Arbutus Biopharma Co. (3.08%), Aerovate Therapeutics, Inc. (10.43%), Y-mAbs Therapeutics, Inc. (7.47%), Avid Bioservices, Inc. (17.42%), Applied Therapeutics, Inc. (3.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short COMPASS Pathways stock? Short selling CMPS is an investing strategy that aims to generate trading profit from COMPASS Pathways as its price is falling. CMPS shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against COMPASS Pathways? A short squeeze for COMPASS Pathways occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMPS, which in turn drives the price of the stock up even further. How often is COMPASS Pathways' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMPS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SIGA Technologies Short Interest Data Altimmune Short Interest Data Olema Pharmaceuticals Short Interest Data Harrow Short Interest Data IGM Biosciences Short Interest Data Arbutus Biopharma Short Interest Data Aerovate Therapeutics Short Interest Data Y-mAbs Therapeutics Short Interest Data Avid Bioservices Short Interest Data Applied Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMPS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldUrgent Nvidia WarningAltimetryDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyShocking: One AI startup's revenue could surge 4,735%Manward PressThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star